← FDA Drug Approvals (Drugs@FDA)

OLANZAPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HISUN PHARM HANGZHOU · Approved 2020-12-31

Drug application

FDA Application #

ANDA206924

Application type

Abbreviated New Drug Application (Generic)

Brand name

OLANZAPINE

Generic name

OLANZAPINE

Active ingredients

OLANZAPINE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

HISUN PHARM HANGZHOU

Manufacturer

Hisun Pharmaceuticals USA, Inc.

First approval

2020-12-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown